免疫原性
癌症免疫疗法
免疫原性细胞死亡
抗原
免疫疗法
抗原性
接种疫苗
癌症疫苗
癌症研究
免疫学
免疫系统
佐剂
医学
癌症
主动免疫治疗
癌细胞
免疫
生物
程序性细胞死亡
免疫
卵巢癌
细胞
作者
Yi Wu,Namei Wu,Youcui Xu,Chen Yang,Han Zhou,Wei Jiang,Jizhou Shen,Hang Liu,Min Li
出处
期刊:Nano Letters
[American Chemical Society]
日期:2025-11-06
卷期号:25 (46): 16346-16355
被引量:2
标识
DOI:10.1021/acs.nanolett.5c03938
摘要
The immunosuppressive nature and low antigenicity of solid tumors present major obstacles for effective cancer vaccination. Here, we report a live bacteria-based vaccine platform engineered by coating attenuated Salmonella ( SAL ) with a cancer cell membrane (CCM), integrating pathogenic adjuvants and autologous tumor antigens into a single entity. This CCM@ SAL system leverages bacterial immunogenicity to induce immunogenic cell death (ICD) within the tumor microenvironment, promoting in situ release of endogenous antigens and damage-associated molecular patterns. These events synergize to prime antigen-presenting cells and activate tumor-specific T cells. Notably, CCM coating reduces bacterial clearance by phagocytes and enhances tumor accumulation. The combination of ICD induction and tumor-targeted antigen delivery enables a self-amplifying vaccination cycle within the tumor. This in situ vaccination induces durable systemic immunity and suppresses tumor progression in multiple murine models. By integrating tumor targeting, ICD induction, and antigen presentation, CCM@ SAL offers a broadly applicable strategy to improve cancer vaccine efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI